Home
Search Center
Journal List
CMA
Contact US
|
Chinese
You Position:
Home
> Journal Detail
All Issues
2024:
Issue 1 |
2023:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2022:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2021:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2020:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2019:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2018:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2017:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2016:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
2015:
Issue 1 |
Issue 2 |
Issue 3 |
Issue 4 |
Chronic Diseases and Translational Medicine
ISSN:
2095-882X
CN:
10-1249/R
Founded in:
2015
Sponsor:
中国科学技术协会
Indexed in:
EMBase
ISTIC
MEDLINE
CSCD
Email:
cdtm@cmaph.org
Publication presents
No Publication presents available
Latest updates
1:
Differences in clinicopathological characteristics between lipohypertrophy and localized insulin-derived amyloidosis: A scoping review
(Mukai Kanae Tanno Hiromasa Sugama Junko Yanagita Toshihiko Kanno Emi)
2:
Corrigendum: Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority phase III trail
(No author available)
3:
Adaptive ultra-hypofractionated whole-pelvic radiotherapy in high-risk and very high-risk prostate cancer on 1.5-Tesla MR-Linac: Estimated delivered dose and early toxicity results
(Gao Linrui Wei Ran Qin Shirui Tian Yuan Xia Wenlong Song Yongwen Wang Shulian Fang Hui Tang Yu Jing Hao Liu Yueping Tang Yuan Qi Shunan Chen Bo Li Yexiong Xing Nianzeng Lu Ningning)
4:
Diabetes mellitus: Is Pakistan the epicenter of the next pandemic?
(Shahid Muhammad Bilal Saeed Mahnoor Naeem Hamza Kumari Usha)
5:
Cost effectiveness of nonpharmacological prevention programs for diabetes: A systematic review of trial-based studies
(Xiong Yongyi Huo Zhaohua Wong Samuel Y. S. Yip Benjamin H. K.)
6:
Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone
(Lan Xialu Zhang Fujing Yang Chen Su Wei Du Jianhua Liu Shuangjiao Chen Miao Han Bing Zhou Daobin Zhuang Junling)
7:
LDL-C rebound after long-term evolocumab treatment and intravascular imaging evidence in a familial hypercholesterolemia patient with early-onset myocardial infarction
(Li Zhifan Zhang Shuang Yin Zheng Zhang Wenjia Sui Yonggang Li Jianjun Dou Kefei Qian Jie Wu Naqiong)
8:
Magnetic resonance imaging-guided focused ultrasound thalamotomy launch with remote telemedicine international proctorship
(Buzaev Igor V. Galimova Rezida M. Nabiullina Dinara I. Illarioshkin Sergey N. Zagidullin Naufal Sh. Safin Shamil M.)
9:
Clinical characteristics of delayed generalized erythema associated with cytarabine
(Jiang He Lu Jun Wang Mei)
10:
Advances in the treatment of IgA nephropathy with biological agents
(Zhuang Yongze Lu Hailing Li Junxia)
11:
Prognostic role of C-reactive protein to albumin ratio in lung cancer: An updated systematic review and meta-analysis
(Lu Zhendong Fu Siyun Li Wei Gao Xiang Wang Jinghui)
WanfangData CO.,Ltd All Rights Reserved
About WanfangData
|
Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:
yiyao@wanfangdata.com.cn